Piper Sandler analyst issues OVERWEIGHT recommendation for BILL on November 3, 2023 02:39PM ET. The previous analyst recommendation was Overweight.BILL was trading at $66.35 at issue of the analyst recommendation.The...
Needham analyst issues BUY recommendation for BILL on November 3, 2023 02:39PM ET. The previous analyst recommendation was Buy.BILL was trading at $66.35 at issue of the analyst recommendation.The overall...
Goldman Sachs analyst issues BUY recommendation for APPN on November 3, 2023 01:00PM ET. The previous analyst recommendation was Buy.APPN was trading at $39.2 at issue of the analyst recommendation.The...
Stephens analyst issues OVERWEIGHT recommendation for CYBR on November 3, 2023 12:33PM ET. The previous analyst recommendation was Overweight.CYBR was trading at $177.58 at issue of the analyst recommendation.The overall...
Wedbush analyst issues OUTPERFORM recommendation for CYBR on November 3, 2023 12:33PM ET. The previous analyst recommendation was Outperform.CYBR was trading at $177.58 at issue of the analyst recommendation.The overall...
Morgan Stanley analyst issues OVERWEIGHT recommendation for CYBR on November 3, 2023 12:33PM ET. The previous analyst recommendation was Overweight.CYBR was trading at $177.58 at issue of the analyst recommendation.The...
Raymond James analyst issues OUTPERFORM recommendation for AAPL on November 3, 2023 12:32PM ET. The previous analyst recommendation was Outperform.AAPL was trading at $176.33 at issue of the analyst recommendation.The...
Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for SWKS on November 3, 2023 12:18PM ET. The previous analyst recommendation was Equal-Weight.SWKS was trading at $90.8 at issue of the analyst recommendation.The...
Susquehanna analyst issues POSITIVE recommendation for SWKS on November 3, 2023 12:18PM ET. The previous analyst recommendation was Positive.SWKS was trading at $90.8 at issue of the analyst recommendation.The overall...
Goldman Sachs analyst issues BUY recommendation for MRNA on November 3, 2023 12:26PM ET. The previous analyst recommendation was Buy.MRNA was trading at $77.14 at issue of the analyst recommendation.The...
